When it comes to fighting cancer or living with a cancer diagnosis, does what you eat make a difference? On Mayo Clinic Q&A, Dr. John Shin, a hematologist/oncologist, discusses nutrition and cancer.
The genius aspergillus is a Fungus extremely common throughout the world. It is in the air almost everywhere, and it’s estimated that most people breathe hundreds of Aspergillus spores into their lungs daily. It affects almost exclusively people with compromised immune systems or with underlying respiratory illness.
COMPROMISED IMMUNITY is often present in people with diabetes, obesity and malnutrition, The very young and very old, Viral infections, particularly AIDS and Covid, cancer, autoimmune diseases, organ transplants, and the list goes on. With the advances in medicine in the past few decades, people are being kept alive longer, often by suppressing their own immunity.
UNDERLYING REPIRATORY ILLNESS is disease such as asthma, cystic fibrosis, sarcoidosis, tuberculosis and COPD.
When I was in an allergy practice, we were always on the alert for allergic bronchopulmonary aspergillosis in asthmatics who were difficult to control. ABPA at that time was reported mainly in England, which is unsurprising due to the wet British climate: fungi grow especially well where is wet.
Another unusual phenomenon is the Aspergillus fungus ball in the lungs, which is sometimes discovered only by chest x-ray. That such a dense mass of fungi could be tolerated in the lungs without invading the body is a tribute to the immune system‘s efficacy.
Galactomannan is in the cell wall of aspergillus, and can be used as a diagnostic test. PCR can also be used, shades of COVID-19. Of course x-ray, or microscopic study of tissues are also often used.
It is estimated that aspergillosis accounts for around 600,000 deaths annually. Africa, with its large number of AIDS patients, contributes heavily to this. It’s difficult to know how common it is in the United States, because aspergillus is not a reportable illness. Please check with the following mayo clinic article for more information.
Focal One® high-intensity focused ultrasound uses high-intensity sound waves to destroy a cancer tumor. It’s delivered through a rectal ultrasound probe. There are no incisions. Most patients need no pain medication after treatment. And there are fewer side effects than with radiation therapy or prostate removal.
Professor Ashani Weeraratna has been studying the cancer microenvironment in her lab for the past 17 years. Taking into account that the tissues in our bodies change as we age is important when researching cancer biology. She hopes that gaining a better understanding of how the growth of cancer cells is affected by their direct cellular ‘neighbourhood’, especially when we age, could be key to developing better treatments for patients with cancer. Read more in
Multiple myeloma is a relatively uncommon form of blood cancer that affects less than 1% of the U.S. population, according the American Cancer Society. People younger than 45 rarely get the disease, and it occurs more in older men than women. And your risk is doubled if you’re African American.
Colorectal cancer is a leading cancer among men and women around the world. Many colorectal cancers are likely to spread to other organs, with the most common site of metastases being the liver. In this Mayo Clinic Minute, Dr. Sean Cleary, a hepatobiliary and pancreas surgeon at Mayo Clinic explains what this means to patients.
Known as the Ironman, Hall of Famer Cal Ripken Jr. was diagnosed with prostate cancer during the COVID-19 pandemic. Partnering with the Brady Urological Institute, Mr. Ripken had a successful robotic radical prostatectomy to remove his tumor and is now deemed cancer free. Watch urologic surgeon Mohamad Allaf and Cal Ripken Jr. discuss his prostate cancer journey at Johns Hopkins and share his powerful message to men across the world.
Colorectal cancer is comprised of colon cancer and rectal cancer, which originate in the lower portion of the large intestine and into the rectum. As with other cancers, screening for early detection should not be delayed. “The vast majority of the time, we don’t know exactly what causes any specific cancer,” says Dr. Jeremy Jones, a Mayo Clinic oncologist. “But there are a number of factors that can increase the risk of developing colon or rectal cancer.” Dr. Jones says one risk factor is increasing age. However, he adds that over the last 30 years younger patients have seen a 50% increased risk of developing colon and rectal cancers. In this Mayo Clinic Q&A podcast, Dr. Jones talks about risk factors, symptoms, treatment, health care disparities and the latest in colorectal cancer research. ____________________________________________